Literature DB >> 27091328

Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.

Oliver G Abela1, Chowdhury H Ahsan1, Fadi Alreefi2, Negar Salehi3, Imran Baig2, Abed Janoudi2, George S Abela4,5,6.   

Abstract

Persistent inflammation and mechanical injury associated with cholesterol crystal accretion within atherosclerotic plaques typically precedes plaque disruption (rupture and/or erosion) and thrombosis--often the terminal events of atherosclerotic cardiovascular disease. To elucidate the mechanisms of these events, the atherosclerotic rabbit model provides a unique and powerful tool that facilitates studies of atherogenesis starting with plaque buildup to eventual disruption. Examination of human coronary arteries obtained from patients who died with myocardial infarction demonstrates evidence of cholesterol crystals perforating the plaque cap and intimal surface of the arterial wall that can lead to rupture. These observations were made possible by omitting ethanol, an avid lipid solvent, from the tissue processing steps. Importantly, the atherosclerotic rabbit model exhibits a similar pathology of cholesterol crystals perforating the intimal surface as seen in ruptured human plaques. Local and systemic inflammatory responses in the model are also similar to those observed in humans. The strong parallel between the rabbit and human pathology validates the atherosclerotic rabbit model as a predictor of human pathophysiology of atherosclerosis. Thus, the atherosclerotic rabbit model can be used with confidence to evaluate diagnostic imaging and efficacy of novel anti-atherosclerotic therapy.

Entities:  

Keywords:  Atherosclerosis; Cholesterol crystals; Inflammation; Plaque rupture; Rabbit model

Mesh:

Year:  2016        PMID: 27091328     DOI: 10.1007/s11883-016-0587-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  74 in total

1.  Oxidized low-density lipoprotein and atherosclerosis.

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

2.  Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques.

Authors:  S S Katz; G G Shipley; D M Small
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 3.  Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier.

Authors:  J E Muller; G S Abela; R W Nesto; G H Tofler
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

4.  MRI of atherothrombosis associated with plaque rupture.

Authors:  Jason Viereck; Frederick L Ruberg; Ye Qiao; Alexandra S Perez; Kara Detwiller; Michael Johnstone; James A Hamilton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-04       Impact factor: 8.311

Review 5.  Receptor-mediated endocytosis: insights from the lipoprotein receptor system.

Authors:  M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  A robust rabbit model of human atherosclerosis and atherothrombosis.

Authors:  Alkystis Phinikaridou; Kevin J Hallock; Ye Qiao; James A Hamilton
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

7.  Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.

Authors:  Y Watanabe; T Ito; M Shiomi; Y Tsujita; M Kuroda; M Arai; M Fukami; A Tamura
Journal:  Biochim Biophys Acta       Date:  1988-06-15

8.  Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.

Authors:  G S Abela; P D Picon; S E Friedl; O C Gebara; A Miyamoto; M Federman; G H Tofler; J E Muller
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro.

Authors:  G S Abela; S J Normann; D M Cohen; D Franzini; R L Feldman; F Crea; A Fenech; C J Pepine; C R Conti
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

View more
  6 in total

Review 1.  Coronary Artery Plaque Imaging.

Authors:  Yibin Xie; Hang Jin; Mengsu Zeng; Debiao Li
Journal:  Curr Atheroscler Rep       Date:  2017-09       Impact factor: 5.113

Review 2.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

Authors:  Austin C Boese; Seong C Kim; Ke-Jie Yin; Jean-Pyo Lee; Milton H Hamblin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

3.  Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.

Authors:  Ashley F Stein-Merlob; Tetsuya Hara; Jason R McCarthy; Adam Mauskapf; James A Hamilton; Vasilis Ntziachristos; Peter Libby; Farouc A Jaffer
Journal:  Circ Cardiovasc Imaging       Date:  2017-05       Impact factor: 7.792

Review 4.  Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.

Authors:  James A Hamilton; Hatice Hasturk; Alpdogan Kantarci; Charles N Serhan; Thomas Van Dyke
Journal:  Curr Atheroscler Rep       Date:  2017-11-06       Impact factor: 5.113

5.  The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury.

Authors:  Manish Jain; Aurélien Frobert; Jérémy Valentin; Stéphane Cook; Marie-Noëlle Giraud
Journal:  J Vis Exp       Date:  2017-10-03       Impact factor: 1.355

6.  Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment.

Authors:  Layan A El-Khatib; Heather De Feijter-Rupp; Abed Janoudi; Levi Fry; Michael Kehdi; George S Abela
Journal:  Open Heart       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.